Dabrafenib plus trametinib for compassionate use in metastatic melanoma: A STROBE-compliant retrospective observational postauthorization study

  1. Martín Algarra, S.
  2. Soriano, V.
  3. Fernández-Morales, L.
  4. Berciano-Guerrero, M.
  5. Mujika, K.
  6. Manzano, J.L.
  7. Puértolas Hernández, T.
  8. Soria, A.
  9. Rodríguez-Abreu, D.
  10. Espinosa Arranz, E.
  11. Medina Martínez, J.
  12. Márquez-Rodas, I.
  13. Rubió-Casadevall, J.
  14. Ortega, M.E.
  15. Jurado García, J.M.
  16. Lecumberri Biurrun, M.J.
  17. Palacio, I.
  18. Rodríguez de la Borbolla Artacho, M.
  19. Altozano, J.P.
  20. Castellón Rubio, V.E.
  21. García, A.
  22. Luna, P.
  23. Ballesteros, A.
  24. Fernández, O.
  25. López Martín, J.A.
  26. Berrocal, A.
  27. Arance, A.
  28. Show all authors +
Journal:
Medicine

ISSN: 1536-5964

Year of publication: 2017

Volume: 96

Issue: 52

Pages: e9523

Type: Article

DOI: 10.1097/MD.0000000000009523 GOOGLE SCHOLAR lock_openOpen access editor

Sustainable development goals

Data source: Scopus